StockData
Twist Bioscience Corp logo

Twist Bioscience Corp (TWST) stock

TWSTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Nov 16, 2026Score 13/30231% above fair value
$116.35+4.35 (+3.88%)

Close on Nov 18, 2026Market cap $7.30BP/E –Yield –

Twist Bioscience revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Twist Bioscience's revenue for the twelve months ending Jun 30, 2026 was $431.80M, up 19.2% year over year. For fiscal 2025 it was $376.57M, up 20.3% from the year before. The highest annual figure on record is $376.57M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Sep 30, 2025$376.57M+20.3%
FY2024Sep 30, 2024$312.97M+27.7%
FY2023Sep 30, 2023$245.11M+20.4%
FY2022Sep 30, 2022$203.57M+53.8%
FY2021Sep 30, 2021$132.33M+46.9%
FY2020Sep 30, 2020$90.10M+65.7%
FY2019Sep 30, 2019$54.39M+113.9%
FY2018Sep 30, 2018$25.43M+136.2%
FY2017Sep 30, 2017$10.77M–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jun 30, 2026$118.38M+23.2%
Q2 FY2026CQ1 2026Mar 31, 2026$110.72M+19.3%
Q1 FY2026CQ4 2025Dec 31, 2025$103.70M+16.9%
Q4 FY2025CQ3 2025Sep 30, 2025$99.01M+16.9%
Q3 FY2025CQ2 2025Jun 30, 2025$96.06M+17.9%
Q2 FY2025CQ1 2025Mar 31, 2025$92.79M+23.2%
Q1 FY2025CQ4 2024Dec 31, 2024$88.71M+24.1%
Q4 FY2024CQ3 2024Sep 30, 2024$84.71M+26.5%
Q3 FY2024CQ2 2024Jun 30, 2024$81.46M+27.8%
Q2 FY2024CQ1 2024Mar 31, 2024$75.30M+25.1%
Q1 FY2024CQ4 2023Dec 31, 2023$71.50M+31.8%
Q4 FY2023CQ3 2023Sep 30, 2023$66.95M+16.8%
Q3 FY2023CQ2 2023Jun 30, 2023$63.74M+13.6%
Q2 FY2023CQ1 2023Mar 31, 2023$60.18M+25.0%
Q1 FY2023CQ4 2022Dec 31, 2022$54.24M+29.1%
Q4 FY2022CQ3 2022Sep 30, 2022$57.31M+51.0%
Q3 FY2022CQ2 2022Jun 30, 2022$56.11M+60.2%
Q2 FY2022CQ1 2022Mar 31, 2022$48.13M+54.2%
Q1 FY2022CQ4 2021Dec 31, 2021$42.02M+49.2%
Q4 FY2021CQ3 2021Sep 30, 2021$37.95M+17.0%
Q3 FY2021CQ2 2021Jun 30, 2021$35.02M+65.1%
Q2 FY2021CQ1 2021Mar 31, 2021$31.20M+61.7%
Q1 FY2021CQ4 2020Dec 31, 2020$28.16M+64.1%
Q4 FY2020CQ3 2020Sep 30, 2020$32.43M+106.1%
Q3 FY2020CQ2 2020Jun 30, 2020$21.21M+55.9%
Q2 FY2020CQ1 2020Mar 31, 2020$19.30M+42.3%
Q1 FY2020CQ4 2019Dec 31, 2019$17.16M+49.4%
Q4 FY2019CQ3 2019Sep 30, 2019$15.74M+87.2%
Q3 FY2019CQ2 2019Jun 30, 2019$13.60M+107.9%
Q2 FY2019CQ1 2019Mar 31, 2019$13.56M+119.9%
Q1 FY2019CQ4 2018Dec 31, 2018$11.49M+166.5%
Q4 FY2018CQ3 2018Sep 30, 2018$8.41M–
Q3 FY2018CQ2 2018Jun 30, 2018$6.54M–
Q2 FY2018CQ1 2018Mar 31, 2018$6.17M–
Q1 FY2018CQ4 2017Dec 31, 2017$4.31M–

More Twist Bioscience figures

See a number that looks wrong?